Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pleural Mesothelioma (MPM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02611037
What this trial is testing

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaMesothelioma
H. Lee Moffitt Cancer Center and Research Institute 34
Testing effectiveness (Phase 2)UnknownNCT02497053
What this trial is testing

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 70
Early research (Phase 1)Not Yet RecruitingNCT07713732
What this trial is testing

TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

Who this might be right for
Small Cell Lung Cancer ( SCLC )Neuroendocrine CancerMalignant Pleural Mesotheliomas (Mpm)+1 more
Treeline Biosciences, Inc. 120
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT04897022
What this trial is testing

Pembrolizumab and Radiation Therapy in People With Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT00651456
What this trial is testing

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 448
Testing effectiveness (Phase 2)Study completedNCT04480372
What this trial is testing

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Who this might be right for
Malignant Pleural MesotheliomaNon-small Cell Lung Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)Study completedNCT01721018
What this trial is testing

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma
Virttu Biologics Limited 12
Testing effectiveness (Phase 2)UnknownNCT02436733
What this trial is testing

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 64
Testing effectiveness (Phase 2)Study completedNCT00797719
What this trial is testing

Short Neoadjuvant Hemithoracic IMRT for MPM

Who this might be right for
Malignant Pleural Mesothelioma
University Health Network, Toronto 104
Early research (Phase 1)Ended earlyNCT05228015
What this trial is testing

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more
Ikena Oncology 67
Testing effectiveness (Phase 2)Ended earlyNCT00604461
What this trial is testing

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
H. Lee Moffitt Cancer Center and Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Large-scale testing (Phase 3)Study completedNCT01098266
What this trial is testing

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 400
Testing effectiveness (Phase 2)Study completedNCT03560973
What this trial is testing

A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM

Who this might be right for
Mesothelioma
Gruppo Oncologico Italiano di Ricerca Clinica 164
Not applicableStudy completedNCT02467426
What this trial is testing

Isolated Thoracic Perfusion (ITP-F) for MPM

Who this might be right for
Mesothelioma
Medias Klinikum for Surgical Oncology 23
Testing effectiveness (Phase 2)Ended earlyNCT02863055
What this trial is testing

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 37
Large-scale testing (Phase 3)Ended earlyNCT04158141
What this trial is testing

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Who this might be right for
Pleural Biphasic MesotheliomaPleural Epithelioid MesotheliomaStage I Pleural Malignant Mesothelioma AJCC v8+4 more
NRG Oncology 16
Testing effectiveness (Phase 2)Study completedNCT02293005
What this trial is testing

Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

Who this might be right for
Lung CancerMesothelioma
M.D. Anderson Cancer Center 28
Next Page